Roberts David B 4

What Happened

• David B. Roberts, President and Director of Lemaitre Vascular (LMAT), executed an open‑market sale of 8,464 common shares on Feb 27, 2026 for a total of about $903,958 (weighted average $106.80). Separately, on Feb 26, 2026 he received shares from the settlement/vesting of Performance Share Units (PSUs) and dividend equivalent rights (acquisitions at $0.00). A small number of shares were withheld to cover tax obligations related to the PSU vesting.

Key Details

• Primary sale: 8,464 shares sold on 2026-02-27; weighted average price $106.80; total ≈ $903,958. (Execution price range $105.85–$107.30.)
• Awards/settlements on 2026-02-26: acquisitions reported — 1,514 shares (PSU from 12/6/2024), 146 shares (PSU from 2/18/2025), and release of dividend equivalent rights (one-for-one share equivalents).
• Option/derivative activity: small exercise/conversion entries of 3 shares (M code) at $0.00.
• Tax withholding: 134 shares and 13 shares were withheld/treated as disposed to satisfy tax withholding on PSU vesting (F codes) for totals of $15,234 and $1,478 respectively; these withholding transactions are exempt under Rule 16b‑3(e).
• Filing: Form 4 filed 2026-03-02 for transactions dated 2026-02-26 and 2026-02-27. Filing appears to be timely under the two business‑day rule.
• Shares owned after the transactions: not specified in the provided excerpt of the filing.

Context

• Most shares received were from PSU vesting (awards), not open‑market purchases — the large activity here is a sale of vested/settled shares. Tax‑withholding share disposals are routine and exempt. The sale does not by itself indicate a change in company outlook; it reflects a combination of award settlement and an open‑market sale.